feed,title,long_url,short_url
Benzinga,Emergent BioSolutions' Plasma-Based Therapy Candidate Flunks COVID-19 Study; HHS Increases Task Order By $23M,https://benzinga.com/general/biotech/21/04/20477225/emergent-biosolutions-plasma-based-therapy-candidate-flunks-covid-19-study-hhs-increases-task-ord,https://j.mp/3wuR0Y4
